Literature DB >> 20071361

Mass spectrometric identification of aberrantly glycosylated human apolipoprotein C-III peptides in urine from Schistosoma mansoni-infected individuals.

Crina I A Balog1, Oleg A Mayboroda, Manfred Wuhrer, Cornelis H Hokke, André M Deelder, Paul J Hensbergen.   

Abstract

Schistosomiasis is a parasitic infection caused by Schistosoma flatworms, prime examples of multicellular parasites that live in the mammalian host for many years. Glycoconjugates derived from the parasite have been shown to play an important role in many aspects of schistosomiasis, and some of them are present in the circulation of the host. The aim of this study was to identify novel glycoconjugates related to schistosomiasis in urine of Schistosoma mansoni-infected individuals using a combination of glycopeptide separation techniques and in-depth mass spectrometric analysis. Surprisingly, we characterized a heterogeneous population of novel aberrantly O-glycosylated peptides derived from the C terminus of human apolipoprotein C-III (apoC-III) in urine of S. mansoni-infected individuals that were not detected in urine of non-infected controls. The glycan composition of these glycopeptides is completely different from what has been described previously for apoC-III. Most importantly, they lack sialylation and display a high degree of fucosylation. This study exemplifies the potential of mass spectrometry for the identification and characterization of O-glycopeptides without prior knowledge of either the glycan or the peptide sequence. Furthermore, our results indicate for the first time that as a result of S. mansoni infection the glycosylation of a host protein is altered.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20071361      PMCID: PMC2860228          DOI: 10.1074/mcp.M900537-MCP200

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  53 in total

Review 1.  Alteration of protein glycosylation in liver diseases.

Authors:  Bram Blomme; Christophe Van Steenkiste; Nico Callewaert; Hans Van Vlierberghe
Journal:  J Hepatol       Date:  2008-12-27       Impact factor: 25.083

Review 2.  Methods in enzymology: O-glycosylation of proteins.

Authors:  Jasna Peter-Katalinić
Journal:  Methods Enzymol       Date:  2005       Impact factor: 1.600

3.  Apolipoprotein C-III0 lacks carbohydrate residues: use of mass spectrometry to study apolipoprotein structure.

Authors:  Y Ito; J L Breslow; B T Chait
Journal:  J Lipid Res       Date:  1989-11       Impact factor: 5.922

4.  Mutagenesis of the glycosylation site of human ApoCIII. O-linked glycosylation is not required for ApoCIII secretion and lipid binding.

Authors:  A Roghani; V I Zannis
Journal:  J Biol Chem       Date:  1988-12-05       Impact factor: 5.157

5.  Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice.

Authors:  Y Ito; N Azrolan; A O'Connell; A Walsh; J L Breslow
Journal:  Science       Date:  1990-08-17       Impact factor: 47.728

6.  Mass spectrometric detection of urinary oligosaccharides as markers of Schistosoma mansoni infection.

Authors:  Marjolein L M Robijn; Joost Planken; Dieuwke Kornelis; Cornelis H Hokke; André M Deelder
Journal:  Trans R Soc Trop Med Hyg       Date:  2007-11-09       Impact factor: 2.184

7.  O-glycoside biomarker of apolipoprotein C3: responsiveness to obesity, bariatric surgery, and therapy with metformin, to chronic or severe liver disease and to mortality in severe sepsis and graft vs host disease.

Authors:  Stephen B Harvey; Yan Zhang; Joshua Wilson-Grady; Teresa Monkkonen; Gary L Nelsestuen; Raj S Kasthuri; Michael R Verneris; Troy C Lund; E Wesley Ely; Gordon R Bernard; Harald Zeisler; Monika Homoncik; Bernd Jilma; Therese Swan; Todd A Kellogg
Journal:  J Proteome Res       Date:  2009-02       Impact factor: 4.466

8.  The immunologically reactive O-linked polysaccharide chains derived from circulating cathodic antigen isolated from the human blood fluke Schistosoma mansoni have Lewis x as repeating unit.

Authors:  G J Van Dam; A A Bergwerff; J E Thomas-Oates; J P Rotmans; J P Kamerling; J F Vliegenthart; A M Deelder
Journal:  Eur J Biochem       Date:  1994-10-01

9.  Molecular cloning of a human apoC-III variant: Thr 74----Ala 74 mutation prevents O-glycosylation.

Authors:  H Maeda; R K Hashimoto; T Ogura; S Hiraga; H Uzawa
Journal:  J Lipid Res       Date:  1987-12       Impact factor: 5.922

10.  Neglected tropical diseases in sub-saharan Africa: review of their prevalence, distribution, and disease burden.

Authors:  Peter J Hotez; Aruna Kamath
Journal:  PLoS Negl Trop Dis       Date:  2009-08-25
View more
  17 in total

1.  Discovery of a new Pro-Pro endopeptidase, PPEP-2, provides mechanistic insights into the differences in substrate specificity within the PPEP family.

Authors:  Oleg I Klychnikov; Tatiana M Shamorkina; Stephen D Weeks; Hans C van Leeuwen; Jeroen Corver; Jan W Drijfhout; Peter A van Veelen; Nikolai N Sluchanko; Sergei V Strelkov; Paul J Hensbergen
Journal:  J Biol Chem       Date:  2018-05-23       Impact factor: 5.157

2.  Alterations in glycopeptides associated with herceptin treatment of human breast carcinoma mcf-7 and T-lymphoblastoid cells.

Authors:  Erika Lattová; Dorota Bartusik; Vic Spicer; Julia Jellusova; Hélène Perreault; Boguslaw Tomanek
Journal:  Mol Cell Proteomics       Date:  2011-05-24       Impact factor: 5.911

Review 3.  Mass spectrometric immunoassays for discovery, screening and quantification of clinically relevant proteoforms.

Authors:  Olgica Trenchevska; Randall W Nelson; Dobrin Nedelkov
Journal:  Bioanalysis       Date:  2016-07-11       Impact factor: 2.681

4.  Development of multiplex mass spectrometric immunoassay for detection and quantification of apolipoproteins C-I, C-II, C-III and their proteoforms.

Authors:  Olgica Trenchevska; Matthew R Schaab; Randall W Nelson; Dobrin Nedelkov
Journal:  Methods       Date:  2015-03-07       Impact factor: 3.608

5.  Longitudinal analysis of maternal plasma apolipoproteins in pregnancy: a targeted proteomics approach.

Authors:  Shannon K Flood-Nichols; Deborah Tinnemore; Mark A Wingerd; Ali I Abu-Alya; Peter G Napolitano; Jonathan D Stallings; Danielle L Ippolito
Journal:  Mol Cell Proteomics       Date:  2012-10-10       Impact factor: 5.911

6.  Targeted glycoproteomic analysis reveals that kappa-5 is a major, uniquely glycosylated component of Schistosoma mansoni egg antigens.

Authors:  Moniek H J Meevissen; Crina I A Balog; Carolien A M Koeleman; Michael J Doenhoff; Gabriele Schramm; Helmut Haas; André M Deelder; Manfred Wuhrer; Cornelis H Hokke
Journal:  Mol Cell Proteomics       Date:  2011-03-03       Impact factor: 5.911

7.  Human urinary glycoproteomics; attachment site specific analysis of N- and O-linked glycosylations by CID and ECD.

Authors:  Adnan Halim; Jonas Nilsson; Ulla Rüetschi; Camilla Hesse; Göran Larson
Journal:  Mol Cell Proteomics       Date:  2011-12-14       Impact factor: 5.911

8.  Quantification of glycopeptides by multiple reaction monitoring liquid chromatography/tandem mass spectrometry.

Authors:  Ehwang Song; Swetha Pyreddy; Yehia Mechref
Journal:  Rapid Commun Mass Spectrom       Date:  2012-09-15       Impact factor: 2.419

9.  LC-MS/MS identification of the O-glycosylation and hydroxylation of amino acid residues of collagen α-1 (II) chain from bovine cartilage.

Authors:  Ehwang Song; Yehia Mechref
Journal:  J Proteome Res       Date:  2013-07-23       Impact factor: 4.466

10.  A novel secreted metalloprotease (CD2830) from Clostridium difficile cleaves specific proline sequences in LPXTG cell surface proteins.

Authors:  Paul J Hensbergen; Oleg I Klychnikov; Dennis Bakker; Vincent J C van Winden; Nienke Ras; Arjan C Kemp; Robert A Cordfunke; Irina Dragan; André M Deelder; Ed J Kuijper; Jeroen Corver; Jan W Drijfhout; Hans C van Leeuwen
Journal:  Mol Cell Proteomics       Date:  2014-03-12       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.